Babson Diagnostics Receives FDA EUA for SARS-CoV-2 IgG Antibody Test
The aC19G1 is a covid-19 serology test that enables the qualitative detection of IgG antibodies to SARS-CoV-2 with 100% sensitivity and 100% specificity.
Read MorePosted by Laurie Bonner | Jun 27, 2020 | Covid 19, Immunoassay Reagents & test Kits |
The aC19G1 is a covid-19 serology test that enables the qualitative detection of IgG antibodies to SARS-CoV-2 with 100% sensitivity and 100% specificity.
Read MorePosted by Laurie Bonner | Jun 26, 2020 | Compliance, Covid 19 |
The updates clarify FDA’s previous recommendations for demonstrating clinical performance and presenting validation data and provide new recommendations.
Read MorePosted by Laurie Bonner | Jun 26, 2020 | Covid 19 |
The SARS-CoV-2 antibodies are being sourced by diagnostic developers for applications such as lateral flow assays and ELISAs.
Read MorePosted by Laurie Bonner | Jun 26, 2020 | Covid 19 |
The model-building program is open access and can be found from the home page of Charmm-GUI, a program that simulates complex biomolecular systems.
Read MorePosted by Laurie Bonner | Jun 26, 2020 | Covid 19 |
The nucleic acid assay is for the qualitative detection of SARS-CoV-2 nucleic acids in respiratory samples from individuals who are suspected of covid-19.
Read More